Live Breaking News & Updates on Golu Timothy

Stay updated with breaking news from Golu timothy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Short Interest in DICE Therapeutics, Inc. (NASDAQ:DICE) Expands By 13.5%

DICE Therapeutics, Inc. (NASDAQ:DICE – Get Free Report) was the target of a large growth in short interest in July. As of July 15th, there was short interest totalling 4,880,000 shares, a growth of 13.5% from the June 30th total of 4,300,000 shares. Based on an average daily volume of 1,590,000 shares, the short-interest ratio […] ....

Golu Timothy , Stifel Nicolaus , Life Insurance Co , Dice Therapeutics Inc , Canaccord Genuity Group , Investment Advisers , Securities Exchange Commission , Therapeutics Inc , Northpond Ventures Gp Llc , Ameritas Advisory Services , Cantor Fitzgerald , Tower Research Capital , Get Free Report , Genuity Group , Exchange Commission , Advisory Services , Research Capital , Life Insurance ,

Stifel Nicolaus Lowers DICE Therapeutics (NASDAQ:DICE) to Hold

Stifel Nicolaus downgraded shares of DICE Therapeutics (NASDAQ:DICE – Get Rating) from a buy rating to a hold rating in a research report report published on Tuesday morning, The Fly reports. DICE has been the subject of several other research reports. Cowen assumed coverage on shares of DICE Therapeutics in a research report on Wednesday, […] ....

Stifel Nicolaus , Golu Timothy , Scottm Robertson , Therapeutics Inc , Blackrock Inc , Jpmorgan Chase Co , York Mellon Corp , Metlife Investment Management , Canaccord Genuity Group , Wells Fargo Company , Get Rating , New York Mellon Corp , Life Investment Management ,